Aims Ketamine is a general anesthetic. Dissociative effects and low cost led ketamine
becoming an illegal recreational drug in young adults. Ketamine‐induced uropathy (KIU) is …

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a multifactorial, chronic bladder
disorder with limited therapeutic options currently available. The present review provides an …

There are still no definite treatment modalities for interstitial cystitis (IC). Meanwhile, stem
cell therapy is rising as potential alternative for various chronic diseases. This study aimed to …

Rationale: Mesenchymal stem cell (MSC) therapy may be a novel approach to improve
interstitial cystitis/bladder pain syndrome (IC/BPS), an intractable disease characterized by …

Stem cells are capable of self-renewal and differentiation into a range of cell types and
promote the release of chemokines and progenitor cells necessary for tissue regeneration …

Mesenchymal stem cell (MSC) therapy is a promising treatment for various intractable
disorders including interstitial cystitis/bladder pain syndrome (IC/BPS). However, an analysis …

Therapeutic options for non-Hunner type interstitial cystitis (IC), which is histologically
characterized by fibrosis and mast cell infiltration, are limited. We developed a rat model that …

Background The therapeutic effects of human embryonic stem cell-derived multipotent
mesenchymal stem cells (M-MSCs) were evaluated for detrusor underactivity (DUA) in a rat …

Background Partial bladder outlet obstruction (pBOO) is characterized by an initial
inflammatory response that progresses to smooth muscle hypertrophy and fibrosis. Current …

Aims Long‐term or recreational use of ketamine affects the urinary system and can result in
ketamine‐induced cystitis (KIC). Rodent models of KIC are important to study KIC …